Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06696027Recruiting
Loss of Y chromosome in autoimmune and lung disease
This study looks at how the loss of the Y chromosome in blood cells may be linked to autoimmune and lung diseases in older men. By joining, you help researchers understand this connection better.
Bonn, North Rhine-WestphaliaAges 50 years+ - NCT06698159Recruiting
Wider pulmonary vein isolation in AFib ablation with single-shot cryoablation
This study tests a new approach to a common procedure for atrial fibrillation (AFib) called pulmonary vein isolation. It uses a single-shot cryoablation technique to treat people with paroxysmal or persistent AFib.
Pozzilli, IserniaAges 18 years+ - NCT06702696Recruiting
Study on aronia berries for COPD inflammation
This trial tests whether eating aronia berries (black chokeberries) can help reduce inflammation in people with COPD. It may offer a natural way to manage COPD symptoms.
Istanbul, ZeytinburnuAges 50–80 - NCT06706596Recruiting
TB screening for high-risk groups in Barcelona
This trial offers free tuberculosis (TB) testing for people who are at high risk for the disease. It aims to find TB early so it can be treated quickly.
BadalonaAges Any age - NCT06707649Recruiting
Self-management education and phone support for COPD
This study tests whether teaching patients how to manage their COPD at home, along with regular phone check-ins, helps them recover better after a hospital stay for a COPD flare-up.
KırşehirAges 18 years+ - NCT07602192Recruiting
Chest Imaging and Blood Tests to Distinguish Asthma From COPD
This study uses chest CT scans and blood tests to better tell asthma and COPD apart and predict which treatments will work best for you. The goal is to help doctors diagnose and treat these lung conditions more accurately.
Seoul, Dongjak-guAges 19 years+ - NCT06713382RecruitingPhase 2
Saline rinse for trapped lung infections
This trial tests if adding a simple saltwater rinse to standard chest tube drainage helps clear stubborn lung infections. It might be an option if you have an infected fluid pocket in your chest that isn't draining well.
Boston, MassachusettsAges 18 years+ - NCT06714513RecruitingPhase 1
TB vaccine study in older adults aged 55 to 74
This study tests a new tuberculosis (TB) vaccine (ID93+GLA-SE) in healthy adults aged 55 to 74. It aims to see if the vaccine is safe and can help protect against TB, especially in people who may have latent (inactive) TB infection.
Gwangmyeong, Gyeonggi-doAges 55–74 - NCT06717659Recruiting
Probiotics for lung rehab in COPD patients
This trial tests if adding probiotics (healthy bacteria you take as a supplement) to your regular lung rehab program helps people with COPD breathe better and feel stronger.
New Taipei CityAges 18 years+ - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT06727864RecruitingPhase 3
Short-course treatment for low-risk active lung TB
This trial tests a shorter treatment course (instead of the standard 6 months) for people with low-risk active TB in the lungs. It aims to see if the shorter regimen works just as well and has fewer side effects.
New Taipei City, BangiaoAges 20–99 - NCT06732674Recruiting
Home-based care for lung disease in rheumatic conditions
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
OsloAges 18 years+ - NCT06733168Recruiting
Electric imaging to guide breathing machine settings for ARDS
This trial tests whether using a special imaging technique (electrical impedance tomography) to set the breathing machine's pressure can improve oxygen levels and lung function in patients with moderate to severe ARDS, a serious lung condition.
HanoiAges 18 years+ - NCT06739369Recruiting
Arterial stiffness and arthritis features study
This study looks at how stiff your blood vessels (arteries) are and how that relates to arthritis symptoms in people with ankylosing spondylitis. It involves simple tests to measure blood vessel health along with your regular arthritis care.
KırşehirAges 18–85 - NCT06749262Recruiting
Inclined vs. standard exercise for COPD
This study compares walking on an incline to standard walking for people with COPD. It aims to find which exercise method is better for improving breathing and mobility.
Omaha, NebraskaAges 45–80 - NCT06749860RecruitingPhase 2
Targeted drug combo for HER2-positive advanced lung cancer
This trial tests a combination of three drugs (Disitamab Vedotin, Tislelizumab, and Bevacizumab) for people with advanced non-small cell lung cancer that has a specific change in the HER2 gene or protein. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
ShanghaiAges 18 years+ - NCT06749886RecruitingPhase 2
Tislelizumab plus chemo for advanced lung cancer after prior immunotherapy
This trial tests a drug called Tislelizumab (an immunotherapy) combined with chemotherapy for people with advanced NSCLC who have already been helped by a different immunotherapy. It's a second-line option for those who did well on their first immunotherapy but now need another treatment.
ShanghaiAges 18 years+ - NCT06751537Recruiting
Testing a wearable device for COPD severity
This trial tests a wearable device (WearME) that tracks your breathing and activity to see how well it can measure COPD severity. It may help you and your doctor better understand your lung function at home.
Baltimore, MarylandAges 21–100 - NCT06753786Recruiting
Blood thinner timing study for bleeding stroke patients
This study looks at when it is safest to start blood thinners to prevent blood clots (deep vein thrombosis) after a type of bleeding stroke called hypertensive intracerebral hemorrhage. Researchers want to find the best time to start this prevention treatment.
MoscowAges 18 years+ - NCT06753981Recruiting
Triple drug therapy for new PAH patients
This trial tests whether a combination of three medications works well and is safe for people newly diagnosed with pulmonary arterial hypertension (PAH) that is not low-risk. It aims to see if starting with triple therapy early can improve outcomes.
Jinan, ShandongAges 18–80 - NCT06755008Recruiting
Cell repair for lung health in COPD
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
Montpellier, HéraultAges 18 years+ - NCT06756646Recruiting
Aerobic exercise and BFRT for COPD patients
This trial tests if adding a special band (BFRT) to walking or biking can help people with COPD breathe better and get stronger. It may be a good option if you have moderate to very severe COPD and haven't been in a rehab program lately.
Tainan, TaiwanAges 30–85 - NCT06757829Recruiting
Lung function in sickle cell: testing Acu-TENS therapy
This study tests if a gentle electrical nerve stimulation treatment (called Acu-TENS) can help improve your lung function. It's for people with sickle cell disease who are not currently in pain or have other major health issues.
Dokki, Giza GovernorateAges 20–50 - NCT06758700RecruitingPhase 2
Teniposide for advanced small cell lung cancer with c-Myc
This trial tests a chemotherapy drug called teniposide for people with a specific type of advanced small cell lung cancer that has gotten worse after prior treatment. The goal is to see if teniposide helps shrink tumors or slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–75
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.